Y-mAbs Therapeutics, Inc.
YMAB
$8.54
$0.0050.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.94% | -20.38% | -14.50% | -21.31% | -11.49% |
| Total Receivables | -29.07% | -13.83% | -12.32% | 5.52% | 16.07% |
| Inventory | 14.37% | -5.36% | 42.43% | 34.36% | 63.83% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -77.91% | 26.45% | -11.75% | -36.49% | 411.71% |
| Total Current Assets | -27.59% | -16.46% | -11.34% | -13.76% | 9.48% |
|
|
|||||
| Total Current Assets | -27.59% | -16.46% | -11.34% | -13.76% | 9.48% |
| Net Property, Plant & Equipment | 148.75% | -42.79% | -47.49% | -40.29% | -12.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -11.29% | -12.98% | -13.49% | -13.01% | -12.64% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 47.62% | 71.75% | 46.19% | 95.07% | 9.88% |
| Total Assets | -18.62% | -8.68% | -6.23% | -6.18% | 8.79% |
|
|
|||||
| Total Accounts Payable | -25.70% | -31.23% | 9.93% | 3.52% | 40.51% |
| Total Accrued Expenses | 28.66% | 33.93% | 10.52% | 33.36% | -23.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -42.28% | -48.76% | -30.16% | -13.59% | 1.57% |
| Total Finance Division Other Current Liabilities | -75.18% | 45.30% | 42.72% | 13.70% | 243.97% |
| Total Other Current Liabilities | -75.18% | 45.30% | 42.72% | 13.70% | 243.97% |
| Total Current Liabilities | -47.22% | 7.68% | 17.74% | 15.95% | 79.38% |
|
|
|||||
| Total Current Liabilities | -47.22% | 7.68% | 17.74% | 15.95% | 79.38% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 510.65% | -49.49% | -63.25% | -58.76% | 3.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -13.80% | -34.96% | -35.69% | -53.25% | 56.46% |
| Total Liabilities | -38.98% | -4.02% | 3.78% | -0.86% | 75.71% |
|
|
|||||
| Common Stock & APIC | 2.83% | 3.19% | 3.38% | 3.25% | 2.76% |
| Retained Earnings | -4.69% | -6.08% | -6.48% | -5.23% | -5.48% |
| Treasury Stock & Other | -158.45% | 65.21% | 404.23% | -101.95% | 0.38% |
| Total Common Equity | -8.23% | -9.81% | -8.89% | -7.71% | -8.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.23% | -9.81% | -8.89% | -7.71% | -8.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.23% | -9.81% | -8.89% | -7.71% | -8.93% |
|
|
|||||